Amphotericin B: Difference between revisions

From Doc Moates Wiki
Jump to navigation Jump to search
NCLEX nursing pharmacology monographs — batch import
 
Add medication infobox (Drugbox) to monographs
 
Line 1: Line 1:
{{Drugbox
| name = Amphotericin B
| therapeutic = Antifungal
| pharmacologic = Polyene
| onset = IV infusion; lipid formulations reduce toxicity.
| halflife = Long; no routine level.
| routes = IV
| highalert = No
| blackbox = None
| antidote = Supportive care; replace electrolytes.
| pregnancy = Use if clearly needed.
}}
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;">
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;">
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.''
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.''

Latest revision as of 16:09, 17 June 2026

Amphotericin B
Drug monograph · NCLEX study reference
Therapeutic classAntifungal
Pharmacologic classPolyene
Onset / peak / durationIV infusion; lipid formulations reduce toxicity.
Half-life / levelLong; no routine level.
RoutesIV
High-alert (ISMP)No
Black box warningNone
Antidote / reversalSupportive care; replace electrolytes.
Pregnancy / lactationUse if clearly needed.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Amphotericin B — Antifungal; Polyene.

Identification

  • Therapeutic class: Antifungal.
  • Pharmacologic class: Polyene.

Pharmacology

  • Mechanism of action: Binds fungal membrane ergosterol to create pores (fungicidal); reserved for serious systemic mycoses.
  • Onset / peak / duration: IV infusion; lipid formulations reduce toxicity.
  • Half-life / therapeutic level: Long; no routine level.

Clinical use

  • Indications: Severe systemic fungal infections.
  • Usual dose, route, frequency: IV by formulation and weight.
  • Maximum dose / adjustments: Use lipid formulations to reduce nephrotoxicity; premedicate for infusion reactions.

Safety

  • Contraindications: Hypersensitivity.
  • Black box warning: None (the conventional form has a strong nephrotoxicity caution).
  • Interactions: Nephrotoxic drugs, corticosteroids and diuretics (potassium loss), digoxin (hypokalemia toxicity).
  • Pregnancy / lactation: Use if clearly needed.
  • High-alert: No.

Adverse effects

  • Common side effects: Fever, chills, rigors during infusion (often called shake and bake), nausea.
  • Serious effects to report: Nephrotoxicity, hypokalemia and hypomagnesemia, severe infusion reaction.
  • Antidote / reversal: Supportive care; replace electrolytes.

Nursing process

  • Assessment before administration: Renal function, electrolytes, baseline vitals.
  • Interventions during therapy: Premedicate (acetaminophen, diphenhydramine, sometimes hydrocortisone); hydrate; monitor electrolytes; verify the correct formulation.
  • Monitor: Renal function, potassium and magnesium, infusion reactions.
  • Evaluation / expected outcome: Resolution of systemic fungal infection.

Patient teaching

  • Patient teaching: Infusion reactions are common and managed with premedication.
  • Notify provider if: Decreased urination, severe chills, muscle weakness.
  • Administration tips: Confirm formulation (conventional versus lipid); premedicate and hydrate.